Qiagen

$53.19 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Qiagen

QIAGEN N.V. (QIAGEN) is a holding company. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Stock Analysis

last close $53.19
1-mo return -2.8%
3-mo return 5.9%
avg daily vol. 632.21T
52-week high 59
52-week low 45.33
market cap. $11.9B
forward pe 25.5
annual div. -
roe 16.7%
ltg forecast -
dividend yield -
annual rev. $1.8B
inst own. 71.6%
baraka

Subscribe now for daily local and international financial news

Subscribe